Pregnancy and Birth

Interventions before and after birth can reduce the rising maternal mortality ratio.

In a recent study, worse neurodevelopmental outcomes were seen in children born preterm and with postnatal growth failure.

For pregnant women at high risk of preeclampsia, aspirin discontinuation at 24 to 28 weeks’ gestation was comparable to aspirin continuation for preventing preterm preeclampsia, according to recent clinical trial data.

A recent study highlights barriers to pregnancy prevention for women without permanent housing.

A booster dose of mRNA COVID-19 vaccination during pregnancy increases protection of infants from infection and related hospitalization.

A new study offers insights into future guidelines for certain populations of pregnant women during a national pandemic.

Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).

Brian Grosberg, MD, and Stephanie Bakaysa, MD, of Hartford HealthCare Medical Group, offered their clinical perspectives on the recently published survey study on management for migraines during pregnancy.

A genome-wide genetic association study using mendelian randomization provides insight into the causal relationships between HDPs and coronary artery disease and ischemic stroke later in life.

In doing so, the country met the new target of the World Health Organization.

In ProgenyHealth’s 2023 key trends and insights report, vital areas to observe in pregnancy and childbirth are discussed.

In a recent analysis, worse maternal and neonatal outcomes were found when mothers were infected with COVID-19 close to delivery.

In the study, investigators analyzed the Jada System in 800 patients from October 2020 to April 2022 across 16 hospitals in the United States. Results of the study were presented at the SMFM 43rd Annual Pregnancy Meeting in San Francisco, California.

A single oral dose of azithromycin in women in labor planning vaginal delivery significantly reduced the risk of maternal death and sepsis, according to study results presented at the SMFM 43rd Annual Pregnancy Meeting.

The clinical psychologist from Ayer Neuroscience Institute at Hartford Healthcare Headache Center shared some highlights from her recently published survey study on migraine treatment during pregnancy.

The rare condition can lead to life-threatening anemia in the fetus and currently lacks FDA-approved treatments.

Majority of women’s health care providers reported in a survey feeling either somewhat or very comfortable with recommending or continuing acute treatments for pregnant patients with migraine.

In a recent study, an association was found between vaginal metabolites and spontaneous preterm birth.

An analysis of registry data recorded in Denmark over a 4-decade period offers an overview of the risk of acute myocardial infarction and ischemic stroke incurred as a result of preeclampsia during pregnancy and how this risk changes over time.

In a recent study, the infant survival rate among periviable infants varied based on the type of active postnatal care received at certain gestational ages.

An advisory panel for the US Food and Drug Administration voted 14-1 to withdraw 17α-hydroxyprogesterone caproate (Makena; Covis Pharma) from the market.

There was an increased odds of liver injury per exposure-mixture quartile increase for organochlorine pesticides, PBDEs) perfluoroalkyl substances, and metals.

A study published in JAAD International examined the association between psoriasis and adverse pregnancy outcomes (APOs) and found that providers should be on the lookout for ectopic pregnancies (EP) in this population.

Gregory Weiss, MD, provides perspective on a recent study suggesting women with gestational hypertension were at an increased risk of chronic hypertension later in life.

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.

This painful skin disease may lower the odds of live birth and trigger comorbidities.

Intravenous immunoglobulin shows promise as a treatment option for pregnant patients with SARS-CoV-2, influenza, and other respiratory viruses.

At the 2022 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting, one health care provider shows the burgeoning terrain in telehealth options for both practitioner and patient.

At the 2022 American College of Obstetricians and Gynecologists Annual Clinical & Scientific Meeting, 4 health care professionals spoke of disease states caused by climate change, and what HCPs can do to mitigate this crisis.

At the 2022 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, 3 physicians talked about how apps, AI and remote blood pressure monitoring could improve perinatal outcomes and move the diversity, inclusion, and equity needle for women forward.